|
Market Closed -
Other stock markets
|
After hours 01:29:59 am | |||
| 40.79 EUR | +1.67% |
|
40.92 | +0.32% |
| 01:43am | Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment | CI |
| 12:51pm | BAYER AG : Gets a Buy rating from UBS | ZD |
| Capitalization | 3.94TCr 4.61TCr 3.63TCr 3.43TCr 6.37TCr 4,32000Cr 6.53TCr 43TCr 17TCr 2,06300Cr 17TCr 17TCr 7,37000Cr | P/E ratio 2026 * |
20x | P/E ratio 2027 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise value | 7.16TCr 8.39TCr 6.61TCr 6.23TCr 12TCr 7,85300Cr 12TCr 77TCr 30TCr 3,75000Cr 31TCr 31TCr 13,39700Cr | EV / Sales 2026 * |
1.58x | EV / Sales 2027 * | 1.47x |
| Free-Float |
100% | Yield 2026 * |
0.55% | Yield 2027 * | 1.91% |
Last Transcript: Bayer AG
| 1 day | +1.99% | ||
| 1 week | +2.76% | ||
| Current month | +3.57% | ||
| 1 month | +4.24% | ||
| 3 months | +2.72% | ||
| 6 months | +45.78% | ||
| Current year | +10.21% |
| 1 week | 39.09 |  | 41.14 |
| 1 month | 36.88 | | 41.14 |
| Current year | 35.2 | | 49.78 |
| 1 year | 20.47 | | 49.78 |
| 3 years | 18.38 | | 61.91 |
| 5 years | 18.38 | | 67.99 |
| 10 years | 18.38 | | 123.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 01/06/2023 |
| Director of Finance/CFO | 56 | 01/06/2018 | |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Achleitner
BRD | Director/Board Member | 69 | 01/04/2002 |
André van Broich
BRD | Director/Board Member | 55 | 01/04/2012 |
| Director/Board Member | 66 | 01/04/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 4.28% | 962 M€ | |
| -15.24% | 4.1% | 1 M€ | |
| 0.00% | 4.1% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.67% | +2.76% | +102.33% | -32.12% | 4.63TCr | |
| -1.06% | +0.27% | +23.23% | +147.78% | 84TCr | |
| -0.21% | -1.25% | +54.16% | +43.25% | 57TCr | |
| -0.71% | -0.11% | +15.28% | +26.91% | 37TCr | |
| +0.32% | -0.75% | +29.45% | +14.60% | 32TCr | |
| -1.59% | -2.14% | +49.76% | +26.78% | 32TCr | |
| -1.05% | -0.58% | +51.76% | +3.95% | 30TCr | |
| -0.94% | -2.09% | +40.11% | +39.04% | 29TCr | |
| -0.34% | +2.12% | +19.02% | +39.13% | 19TCr | |
| +0.03% | -0.78% | +30.54% | +66.96% | 17TCr | |
| Average | -0.48% | -0.25% | +41.56% | +37.63% | 34.24TCr | |
| Weighted average by Cap. | -0.66% | -0.40% | +35.77% | +59.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.54TCr 5.31TCr 4.18TCr 3.95TCr 7.34TCr 4,97400Cr 7.52TCr 49TCr 19TCr 2,37500Cr 20TCr 20TCr 8,48500Cr | 4.66TCr 5.46TCr 4.3TCr 4.06TCr 7.54TCr 5,11100Cr 7.73TCr 50TCr 20TCr 2,44100Cr 20TCr 20TCr 8,71900Cr |
| Net income | 192.64Cr 225.5Cr 177.62Cr 167.62Cr 311.49Cr 21TCr 319.39Cr 2.08TCr 817.93Cr 10TCr 846.26Cr 828.31Cr 36TCr | 302.76Cr 354.4Cr 279.16Cr 263.44Cr 489.55Cr 33TCr 501.98Cr 3.27TCr 1.29TCr 16TCr 1.33TCr 1.3TCr 57TCr |
| Net Debt | 3.22TCr 3.77TCr 2.97TCr 2.8TCr 5.21TCr 3,53300Cr 5.34TCr 35TCr 14TCr 1,68700Cr 14TCr 14TCr 6,02700Cr | 2.93TCr 3.43TCr 2.7TCr 2.55TCr 4.74TCr 3,21400Cr 4.86TCr 32TCr 12TCr 1,53500Cr 13TCr 13TCr 5,48300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 40.79 € | +1.67% | 16,93,922 |
| 10/26/10 | 40.12 € | -0.82% | 21,59,682 |
| 09/26/09 | 40.45 € | -0.07% | 18,55,752 |
| 08/26/08 | 40.48 € | +3.08% | 28,21,861 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BAYN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition